Martha L Cruz

Martha L Cruz has an extensive work experience spanning over several industries and roles. Martha L is currently working at Acelyrin, Inc. as the Senior Director of Clinical Science since August 2021. Prior to this, they worked at Amgen as the Development Director from August 2020 until November 2021, and as the Strategic Development Director at Amgen Inc from May 2019 until November 2021.

Martha has also worked at Amgen as the Global Regulatory Writing from May 2015 until May 2019, and as the Development Clinical Director for Global Development from July 2008 until May 2015. Before joining Amgen, they worked as an Associate Professor at the University of Texas from July 2005 until July 2008, and as an Assistant Professor/Postdoctoral Research Fellow at the University of Southern California from September 2000 until July 2005.

Additionally, Martha has worked at Universidad del Valle as an Assistant/Associate Professor in Biochemistry from May 1994 until August 2000. Prior to that, they were a Wellcome Trust Research Fellow at the University of Oxford from March 1998 to February 1999, and a Postdoctoral Research Fellow at INSERM U-145 from March 1993 to February 1994.

Throughout their career, Martha L Cruz has gained valuable experience in clinical science, development, regulatory writing, and teaching in various academic and industry settings.

Martha L Cruz began their education at the University of Caldas in 1981 and completed their Doctorate degree in Veterinary Medicine in 1987. Martha L then pursued further academic achievements at the University of Oxford from 1988 to 1992, where they obtained a Doctor of Philosophy (D.Phil) degree in Biochemistry, specializing in Lipid and Lipoprotein Metabolism.